U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Rowinsky Eric K (0001318886)
Mailing Address
IMCLONE SYSTEMS INCORPORATED
180 VARICK STREET, 6TH FLOOR
NEW YORK NY 10014
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Fortress Biotech, Inc. 0001429260 2020-01-01 director
Verastem, Inc. 0001526119 2018-12-31 director
NEOPROBE CORP
Current Name:NAVIDEA BIOPHARMACEUTICALS, INC.		 0000810509 2014-11-10 director
DNIB UNWIND, INC. 0001385228 2014-09-03 director
STEMLINE THERAPEUTICS INC 0001264587 2013-01-28 officer: EVP, Chief Med. Off., Head R&D
BIOGEN INC. 0000875045 2010-03-20 director
Savara Inc 0001160308 2010-02-02 director
TAPESTRY PHARMACEUTICALS, INC 0000891504 2007-12-04 director
IMCLONE SYSTEMS INC/DE
Current Name:IMCLONE SYSTEMS INC		 0000765258 2005-02-21 officer: Chief Medical Officer


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-06-21   BIOGEN INC. 4 A-Award --D 1340.0000 21969.0000 1 0000875045 Common Stock
A 2024-06-18   Verastem, Inc. 4 A-Award --D 12500.0000 12500.0000 2 0001526119 Stock Option (right to buy)
A 2024-06-18   Verastem, Inc. 4 A-Award --D 8333.0000 8333.0000 1 0001526119 Common Stock
A 2024-03-11   Verastem, Inc. 4 A-Award --D 12572.0000 12572.0000 6 0001526119 Stock Option (right to buy)
D 2024-03-11   Verastem, Inc. 4 D-Return --D 2083.0000 0.0000 5 0001526119 Stock Option (right to buy)
D 2024-03-11   Verastem, Inc. 4 D-Return --D 2083.0000 0.0000 4 0001526119 Stock Option (right to buy)
D 2024-03-11   Verastem, Inc. 4 D-Return --D 2083.0000 0.0000 3 0001526119 Stock Option (right to buy)
D 2024-03-11   Verastem, Inc. 4 D-Return --D 2157.0000 0.0000 2 0001526119 Stock Option (right to buy)
D 2024-03-11   Verastem, Inc. 4 D-Return --D 4166.0000 0.0000 1 0001526119 Stock Option (right to buy)
A 2024-02-15   BIOGEN INC. 4 P-Purchase --D 455.0000 20629.0000 1 0000875045 Common Stock
A 2024-01-01   Fortress Biotech, Inc. 4 A-Award --D 6666.0000 68797.0000 1 0001429260 COMMON STOCK, PAR VALUE $0.001
A 2023-06-26   BIOGEN INC. 4 A-Award --D 960.0000 20174.0000 1 0000875045 Common Stock
A 2023-05-15   Verastem, Inc. 4 A-Award --D 62500.0000 62500.0000 1 0001526119 Stock Option (right to buy)
A 2023-02-10   Fortress Biotech, Inc. 4 P-Purchase --D 11976.0000 931976.0000 1 0001429260 COMMON STOCK, PAR VALUE $0.001
A 2023-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 920000.0000 1 0001429260 COMMON STOCK, PAR VALUE $0.001
A 2022-06-22   Verastem, Inc. 4 A-Award --D 62500.0000 62500.0000 1 0001526119 Stock Option (right to buy)
A 2022-06-15   BIOGEN INC. 4 A-Award --D 1370.0000 19214.0000 1 0000875045 Common Stock
A 2022-05-12   Verastem, Inc. 4/A A-Award --D 62500.0000 62500.0000 1 0001526119 Stock Option (right to buy)
A 2022-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 820000.0000 1 0001429260 Common Stock, par value $0.001
A 2021-07-01   BIOGEN INC. 4 A-Award --D 775.0000 17844.0000 1 0000875045 Common Stock
A 2021-06-28   Verastem, Inc. 4 A-Award --D 25000.0000 25000.0000 1 0001526119 Stock Option (right to buy)
D 2021-03-02   Fortress Biotech, Inc. 4 S-Sale --D 10000.0000 720000.0000 6 0001429260 Common Stock, par value $0.001
D 2021-02-19   Fortress Biotech, Inc. 4 S-Sale --D 8000.0000 730000.0000 5 0001429260 Common Stock, par value $0.001
D 2021-02-18   Fortress Biotech, Inc. 4 S-Sale --D 6000.0000 738000.0000 4 0001429260 Common Stock, par value $0.001
D 2021-02-16   Fortress Biotech, Inc. 4 S-Sale --D 2000.0000 744000.0000 3 0001429260 Common Stock, par value $0.001
D 2021-02-05   Fortress Biotech, Inc. 4 S-Sale --D 4000.0000 746000.0000 2 0001429260 Common Stock, par value $0.001
A 2021-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 750000.0000 1 0001429260 Common Stock, par value $0.001
A 2020-06-16   Verastem, Inc. 4 A-Award --D 25000.0000 25000.0000 1 0001526119 Stock Option (Right to Buy)
A 2020-06-03   BIOGEN INC. 4 A-Award --D 890.0000 17069.0000 1 0000875045 Common Stock
A 2020-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 650000.0000 1 0001429260 Common Stock, par value $0.001
A 2019-06-21   Verastem, Inc. 4 A-Award --D 25000.0000 25000.0000 1 0001526119 Stock Option (Right to Buy)
A 2019-06-19   BIOGEN INC. 4 A-Award --D 1155.0000 16179.0000 1 0000875045 Common Stock
A 2019-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 550000.0000 1 0001429260 Common Stock
A 2018-06-12   BIOGEN INC. 4 A-Award --D 880.0000 15024.0000 1 0000875045 Common Stock
A 2018-06-11   Verastem, Inc. 5 A-Award -LD 25891.0000 25891.0000 1 0001526119 Stock Option (Right to Buy)
A 2018-02-20   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 50000.0000 173764.0000 2 0000810509 Stock Option
A 2018-02-20   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 50000.0000 341446.0000 1 0000810509 Common Stock
A 2018-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 450000.0000 1 0001429260 Common Stock
A 2017-09-05   Verastem, Inc. 4 P-Purchase --I 2000.0000 2000.0000 1 0001526119 Common Stock
A 2017-06-30   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 50000.0000 50000.0000 2 0000810509 Stock Option
A 2017-06-30   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 50000.0000 291446.0000 1 0000810509 Common Stock
A 2017-06-13   Verastem, Inc. 4 A-Award --D 50000.0000 50000.0000 1 0001526119 Stock Option (Right to Buy)
A 2017-06-07   BIOGEN INC. 4 A-Award --D 1055.0000 14144.0000 1 0000875045 Common Stock
A 2017-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 350000.0000 1 0001429260 Common Stock, par value $0.001
D 2016-08-29   DNIB UNWIND, INC. 4 M-Exempt --D 15000.0000 0.0000 2 0001385228 Employee Stock Option (Right to Buy)
A 2016-08-29   DNIB UNWIND, INC. 4 M-Exempt --D 15000.0000 15000.0000 1 0001385228 Common Stock
A 2016-06-21   BIND Therapeutics, Inc 4 A-Award --D 15000.0000 15000.0000 1 0001385228 Employee Stock Option (Right to Buy)
A 2016-06-08   BIOGEN INC. 4 A-Award --D 1060.0000 13065.0000 1 0000875045 Common Stock
A 2016-04-20   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 28000.0000 224446.0000 2 0000810509 Common Stock
A 2016-04-08   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 10726.0000 196446.0000 1 0000810509 Common Stock
A 2016-01-01   Fortress Biotech, Inc. 4 A-Award --D 100000.0000 250000.0000 1 0001429260 Common Stock, par value $0.001
A 2015-06-10   BIOGEN INC. 4 A-Award --D 695.0000 12005.0000 1 0000875045 Common Stock
A 2015-06-09   BIND Therapeutics, Inc 4 A-Award --D 15000.0000 15000.0000 1 0001385228 Employee Stock Option (Right to Buy)
D 2015-04-27   STEMLINE THERAPEUTICS INC 4 S-Sale --D 10824.0000 143688.0000 1 0001264587 Common Stock
A 2015-03-26   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 22000.0000 185720.0000 1 0000810509 Common Stock
D 2015-03-20   BIOGEN INC. 4 M-Exempt --D 11667.0000 0.0000 3 0000875045 Stock Option (Right to Buy)
D 2015-03-20   BIOGEN INC. 4 S-Sale --D 11667.0000 11310.0000 2 0000875045 Common Stock
A 2015-03-20   BIOGEN INC. 4 M-Exempt --D 11667.0000 22977.0000 1 0000875045 Common Stock
D 2015-03-19   BIOGEN IDEC INC. 4 M-Exempt --D 2333.0000 11667.0000 3 0000875045 Stock Option (Right to Buy)
D 2015-03-19   BIOGEN IDEC INC. 4 S-Sale --D 2333.0000 11310.0000 2 0000875045 Common Stock
A 2015-03-19   BIOGEN IDEC INC. 4 M-Exempt --D 2333.0000 13643.0000 1 0000875045 Common Stock
D 2015-03-17   BIOGEN IDEC INC. 4 M-Exempt --D 4667.0000 14000.0000 3 0000875045 Stock Option (Right to Buy)
D 2015-03-17   BIOGEN IDEC INC. 4 S-Sale --D 4667.0000 11310.0000 2 0000875045 Common Stock
A 2015-03-17   BIOGEN IDEC INC. 4 M-Exempt --D 4667.0000 15977.0000 1 0000875045 Common Stock
A 2015-03-12   CORONADO BIOSCIENCES INC 4 A-Award --D 50000.0000 150000.0000 2 0001429260 Common Stock, par value $0.001 per share
A 2015-03-12   CORONADO BIOSCIENCES INC 4 A-Award --D 50000.0000 100000.0000 1 0001429260 Common Stock, par value $0.001
D 2015-03-09   BIOGEN IDEC INC. 4 M-Exempt --D 4666.0000 18667.0000 3 0000875045 Stock Option (Right to Buy)
D 2015-03-09   BIOGEN IDEC INC. 4 S-Sale --D 4666.0000 11310.0000 2 0000875045 Common Stock
A 2015-03-09   BIOGEN IDEC INC. 4 M-Exempt --D 4666.0000 15976.0000 1 0000875045 Common Stock
A 2015-03-06   STEMLINE THERAPEUTICS INC 4 A-Award --D 69201.0000 69201.0000 2 0001264587 Stock Options (right to buy)
A 2015-03-06   STEMLINE THERAPEUTICS INC 4 A-Award --D 24379.0000 154512.0000 1 0001264587 Common Stock
D 2015-02-18   STEMLINE THERAPEUTICS INC 4 S-Sale --D 1640.0000 130133.0000 1 0001264587 Common Stock
A 2014-11-10   NAVIDEA BIOPHARMACEUTICALS, INC. 4 A-Award --D 9470.0000 163720.0000 1 0000810509 Common Stock
A 2014-09-03   BIND Therapeutics, Inc 4 A-Award --D 25000.0000 25000.0000 1 0001385228 Stock Option (Right to Buy)
A 2014-06-12   BIOGEN IDEC INC. 4 A-Award --D 870.0000 11310.0000 1 0000875045 Common Stock
D 2014-04-25   STEMLINE THERAPEUTICS INC 4 S-Sale --D 300.0000 131773.0000 2 0001264587 Common Stock
D 2014-04-25   STEMLINE THERAPEUTICS INC 4 S-Sale --D 10879.0000 132073.0000 1 0001264587 Common Stock
A 2014-02-20   CORONADO BIOSCIENCES INC 4 A-Award --D 50000.0000 50000.0000 1 0001429260 Common Stock, par value $0.001
A 2014-02-14   STEMLINE THERAPEUTICS INC 4 A-Award --D 13986.0000 142952.0000 1 0001264587 Common Stock
A 2014-02-14   STEMLINE THERAPEUTICS INC 4 A-Award --D 37636.0000 37636.0000 2 0001264587 Stock Options (right to buy)

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016